NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

AIxCrypto Holdings, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERAIXC
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / AIXC COVERAGE

What’s moving AIxCrypto Holdings, Inc. now

Current reporting with the operating signal separated from the noise.

01
AIxCrypto Holdings, Inc. Elects Jason E. Dodier as A Director, Effective August 24, 2026

AIxCrypto Holdings, Inc. Elects Jason E. Dodier as A Director, Effective August 24, 2026

The development tests whether AIxCrypto Holdings, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
02
AIxCrypto Holdings, Inc. (AIXC) Q2 2026 Earnings Call Transcript

AIxCrypto Holdings, Inc. (AIXC) Q2 2026 Earnings Call Transcript

Investors are testing whether AIxCrypto Holdings, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
AIxCrypto Holdings, Inc.: AIxCrypto Holdings Reports Second Quarter 2026 Results

AIxCrypto Holdings, Inc.: AIxCrypto Holdings Reports Second Quarter 2026 Results

The development tests whether AIxCrypto Holdings, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
04
AIxCrypto Holdings, Inc. (AIXC) Q1 2026 Earnings Call Prepared Remarks Transcript

AIxCrypto Holdings, Inc. (AIXC) Q1 2026 Earnings Call Prepared Remarks Transcript

Investors are testing whether AIxCrypto Holdings, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony ...

Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony ...

Investors are testing whether AIxCrypto Holdings, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest AIXC filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-07 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-11 · Period 2026-03-31SEC ↗10-K/AAnnual financial reportFiled 2026-07-16 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-08-26 · Period 2026-08-21SEC ↗8-KMaterial company eventFiled 2026-08-18 · Period 2026-08-18SEC ↗8-KMaterial company eventFiled 2026-08-07 · Period 2026-08-07SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-12-15 · Period 2025-12-12SEC ↗EFFECTOfficial SEC filingFiled 2026-09-14SEC ↗
EARNINGS / QUARTERLY TRACKER

AIxCrypto Holdings, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.